{"filing":{"accession_number":"0001628280-26-059697","cik":"0001613103","ticker":"MDT","company_name":"Medtronic plc","form":"8-K","filing_date":"2026-09-01","report_date":"2026-09-01","primary_document":"mdt-20260901.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026059697/mdt-20260901.htm"},"events":[{"id":30760,"run_id":28199,"accession_number":"0001628280-26-059697","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"summary":"Medtronic issued a press release on September 1, 2026, announcing its first quarter fiscal 2027 financial results, including revenue of $9.8 billion (13.7% organic growth), GAAP diluted EPS of $1.14, and non-GAAP diluted EPS of $1.45. The company also raised its FY27 organic revenue growth guidance and non-GAAP EPS guidance. This is a standard quarterly earnings disclosure under Item 2.02, material to investors assessing the company's operational performance and forward guidance.","company_name":"Medtronic plc","ticker":"MDT","filing_date":"2026-09-01","form":"8-K","submitted_at":null,"items":[{"id":33465,"accession_number":"0001628280-26-059697","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"Medtronic issued a press release on September 1, 2026, announcing its first quarter fiscal 2027 financial results, including revenue of $9.8 billion (13.7% organic growth), GAAP diluted EPS of $1.14, and non-GAAP diluted EPS of $1.45. The company also raised its FY27 organic revenue growth guidance and non-GAAP EPS guidance. This is a standard quarterly earnings disclosure under Item 2.02, material to investors assessing the company's operational performance and forward guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-01T10:50:10.431063+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":33465,"accession_number":"0001628280-26-059697","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"Medtronic issued a press release on September 1, 2026, announcing its first quarter fiscal 2027 financial results, including revenue of $9.8 billion (13.7% organic growth), GAAP diluted EPS of $1.14, and non-GAAP diluted EPS of $1.45. The company also raised its FY27 organic revenue growth guidance and non-GAAP EPS guidance. This is a standard quarterly earnings disclosure under Item 2.02, material to investors assessing the company's operational performance and forward guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-01T10:50:10.431063+00:00","company_name":"Medtronic plc","ticker":"MDT","filing_date":"2026-09-01"}]}